Relationships between Clinical Outcomes of Coronary Heart Disease of Covid-19 Vaccinated Patients with Hypertension

Coronary heart disease is a disease caused by blockage or narrowing of the coronary arteries due to the process of atherosclerosis which supplies blood flow to the heart and is one of the leading causes of death in the world, and one of the factors causing coronary heart disease is hypertension. Research Purposes: The Relationship between Clinical Outcomes of Coronary Heart Disease Who Have Received the Covid-19 Vaccine and Hypertension at a hospital in Jakarta. Research methods: namely Using a prospective and retrospective cohort analytical observation design. Data collection was conducted at one of the hospitals in Jakarta, between January 2022 - May 2024. Research result: from 110 coronary heart disease patients who had received the covid-19 vaccine, based on gender, the largest number was male with 58 (52.7%), with age <60 years totaling 56 (50.9%), hypertension as many as 103 (93.6%). and the relationship between clinical outcomes of coronary heart disease who had received the covid-19 vaccine and hypertension based on age with the chi square test obtained a p value = 0.544% (p> 0.05%), gender p = 1,000 (p> 0.05%) which is not significant, while the relationship between clinical outcomes of coronary heart disease who had received the covid 19 vaccine and hypertension based on the chi square test obtained a p value = 0.027% (P <0.05%) which is significant. This is due to several other risk factors besides hypertension that are interrelated such as unhealthy lifestyle changes, smoking and an unbalanced diet.